The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...
The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...
Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...